[{"NetIncomeLoss_1_Q3_USD":-18517000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":10057000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":4338000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":27688972.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":31383936.0,"InterestAndOtherIncome_3_Q3_USD":1071000.0,"InterestAndOtherIncome_1_Q3_USD":675000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"OperatingLeasesRentExpenseNet_3_Q3_USD":2244000.0,"OperatingLeasesRentExpenseNet_1_Q3_USD":782000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":138000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-129841000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":218143000.0,"PaymentsToAcquireInvestments_3_Q3_USD":141067000.0,"AssetsCurrent_0_Q3_USD":364089000.0,"OperatingLeaseExpense_3_Q3_USD":2244000.0,"OperatingLeaseExpense_1_Q3_USD":782000.0,"TemporaryEquitySharesOutstanding_0_Q3_shares":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":3687673.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":3687673.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":262000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-1000.0,"CommonStockSharesIssued_0_Q3_shares":38845196.0,"Assets_0_Q3_USD":411874000.0,"ShareBasedCompensation_3_Q3_USD":1765000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":8173222.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":219301000.0,"DepreciationAndAmortization_1_Q3_USD":600000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"DepreciationAndAmortization_3_Q3_USD":1536000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":47368000.0,"ShortTermInvestments_0_Q3_USD":88716000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":46049000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":18939000.0,"TemporaryEquityLiquidationPreference_0_Q3_USD":0.0,"OperatingLeasesFutureMinimumPaymentsDueThereafter_0_Q3_USD":1493000.0,"TemporaryEquitySharesAuthorized_0_Q3_shares":0.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-20576000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q3_USD":3337000.0,"NumberOfReportableSegments_3_Q3_Segment":1.0,"CommonStockValue_0_Q3_USD":39000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q3_USD":168109000.0,"TemporaryEquitySharesIssued_0_Q3_shares":0.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":340150000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q3_USD":830000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-23188000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-18518000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":602000.0,"OtherAssetsNoncurrent_0_Q3_USD":185000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":265527000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_3_Q3_USD":14873000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":391227000.0,"Liabilities_0_Q3_USD":104254000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":140000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-1000.0,"RevenueFromRelatedParties_3_Q3_USD":0.0,"RevenueFromRelatedParties_1_Q3_USD":0.0,"CommonStockDividendsPerShareDeclared_3_Q3_USD":0.0,"ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_3_Q3_USD":119914000.0,"LitigationSettlementExpense_3_Q3_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":4394000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":230711000.0,"CommonStockSharesOutstanding_0_Q3_shares":38845196.0,"RestrictedCashNoncurrent_0_Q3_USD":170000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q3_USD":3332000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":12539000.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q3_USD":3438000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-43904000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-18517000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":1115000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":20402000.0,"LiabilitiesCurrent_0_Q3_USD":41012000.0,"AccountsPayableCurrent_0_Q3_USD":3611000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":265697000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":5990000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":937000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_3_Q3_USD":300000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_1_Q3_USD":57000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q3_security":0.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_3_Q3_USD":0.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_1_Q3_USD":0.0,"SecurityDeposit_0_Q3_USD":91000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":265697000.0,"NumberOfOperatingSegments_3_Q3_Segment":1.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":550000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":6532000.0,"NetIncomeLoss_3_Q3_USD":-23328000.0,"CurrentIncomeTaxExpenseBenefit_1_Q3_USD":0.0,"CurrentIncomeTaxExpenseBenefit_3_Q3_USD":-20600000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-83784000.0,"OperatingLeasesFutureMinimumPaymentsDueInFiveYears_0_Q3_USD":3541000.0,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"OperatingIncomeLoss_3_Q3_USD":-44975000.0,"OperatingIncomeLoss_1_Q3_USD":-19192000.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_3_Q3_USD":579000.0,"IncomeTaxesReceivable_0_Q3_USD":3900000.0,"IncreaseDecreaseInIncomeTaxesReceivable_3_Q3_USD":3856000.0,"IncomeTaxReceivable_0_Q3_USD":3856000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":30299000.0,"PreferredStockValue_0_Q3_USD":null,"LiabilitiesAndStockholdersEquity_0_Q3_USD":411874000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":3761000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":12500000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":440000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":19071000.0,"OperatingExpenses_1_Q3_USD":23277000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.84,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.59,"ProfitLoss_3_Q3_USD":-23328000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":868000.0,"DeferredOfferingCosts_0_Q3_USD":0.0,"OtherLiabilitiesCurrent_0_Q3_USD":958000.0,"StockholdersEquity_0_Q3_USD":307620000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":62374000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":3647000.0,"LongTermInvestments_0_Q3_USD":40898000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-130000.0,"TaxesPayableCurrent_0_Q3_USD":34000.0,"OperatingExpenses_3_Q3_USD":56106000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q3_USD":15971000.0,"Ticker":"NRIX","CIK":"1549595","name":"NURIX THERAPEUTICS, INC.","OfficialName":"Nurix Therapeutics Inc. Common stock","form":"10-Q","period":"20200831","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"593342561.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201014"}]